| 10:45 am–12:30 pm
Oral presentation | Track B: Empirical Findings of Phase 1 and 2 Trials of New Microbicide Products (Including Rectal Microbicides) Heidi Jones, Sarah Braunstein, Tammy Evans-Strickfaden, Neetha S. Morar, Gita Ramjee, Clyde Hart, and Janneke van de Wijgert. "Effect of Carraguard™ gel on cell-free HIV-1 RNA shedding in genital secretions of HIV-positive women: A Phase 1 safety study in Durban, South Africa" (11:45 am) (abstract) | 12:30–1:30 pm
Poster session
| Click here to view poster abstracts
| 1:30–3:00 pm
Oral presentations | Track B & C: Adherence to Trial Procedures and Product Use Matshediso Mtshweni, Maria Manuela Williams, and Khatija Ahmed. "Challenges encountered in recruiting 16- and 17-year-old sexually active females to participate in the CarraguardTM Phase 3 clinical trial in Soshanguve, Pretoria" (1:30 pm) (abstract) Sumentheran N. Govender, Stephanie Skoler, Robin A. Maguire, Laura Guichard, Pekka Lähteenmäki, Hlengiwe Vilakazi, Fridda Mapula, and Jasmine Rossier. "Evaluation of microbicide applicators to determine vaginal use in the Carraguard® Phase 3 clinical trial" (2:30 pm) (abstract)
| 4:00–5:45 pm
| Track D: Trial Updates and Preliminary Data of Phase 2B/3 Microbicide Trials
Gita Ramjee and Janet Darbyshire, Chairs Elof D.B. Johansson. "Population Council Phase 3 study of the efficacy and safety of the microbicide Carraguard™ in preventing HIV seroconversion in women"
| | Tuesday, 25 April | | 10:30 am–12:30 pm
Oral presentation | Track D: Pathways to Access a Successful Microbicide: Advocacy, Policy, and Mobilization Sarah Whitehead, Peter Kilmarx, Kelly Blanchard, Chomnad Manopaiboon, Supaporn Chaikummao, Barbara Friedland, Jullapong Achalapong, Mayuree Wankrairoj, Philip Mock, and Jordan Tappero. "Marketing microbicides for pleasure and protection: Lessons from a couples study" (12:15 pm) (abstract)
| 12:30–1:30 pm
Poster session
| Click here to view poster abstracts
| 3:30–5:00 pm
Panel discussion
| Track B: Microbicides and STIs
Chairs: Sinead Delany and Renee RidzonPanelists: Francis Ndowa, Connie Cellum, Khatija Ahmed (presentation), and Anna Foss
| 4:30–6:00 pm
Satellite symposium | Informed Consent in Clinical Trials
Co-sponsored with Family Health International and Research Triangle Institute (PDF of agenda)
(related link: PDF of 2005 workshop report)
| | Wednesday, 26 April |
| 11:30 am–12:30 pm
Panel discussion | Track B: Testing Methods/Algorithms for Measuring HIV Endpoints
Polly Harrison and Khatija Ahmed, ChairsPanelists: Sharon Hillier, Ute Jentsch, Tania Crucitti, Pekka Lähteenmäki, and Leigh Peterson
| | | | | Abstract book only | M.L. Moropeng, Khatija Ahmed, Maria Manuela Williams, B.L. Mohale, Marlena Gehret, and Joseph Skhosana. "The role of the Quality Control (QC) team in a large Phase 3 HIV prevention clinical trial of Carraguard in Soshanguve, Pretoria, South Africa" (abstract) Andrea Wallace, Aaron Teitelbaum, Livia Wan, Laura Guichard, Robin A. Maguire, and David M. Phillips. "Determining the feasibility of utilizing the microbicide applicator usage assay in clinical trials" (abstract)
|
|
